Product Information
MESALAMINE DR 1.2 GM TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.7809 per EA under NDC 63304017513. Its NADAC has been published 351 times since Jan 15, 2020.
FDA first approved this application on Jan 25, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.2 g/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304017513
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA211858FDA Approved
1/25/2019
TE Code
AB
On Market Since
2/1/2019
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE DR 1.2 GM TABLET has been published 351 times since Jan 15, 2020, and over the history we have for it it has declined 77.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7809 per EA |
|---|---|
| All-time high | $3.5143 (Jan 13, 2021) |
| All-time low | $0.7809 (Sep 23, 2026) |
| 52-week high | $1.0132 |
| 52-week low | $0.7809 |
| Median price | $2.1176 |
| Average price | $2.1171 |
| Largest weekly change | +45.9% (Aug 21, 2024) |
| Weeks tracked | 351 |
| Tracking since | Jan 15, 2020 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mesalamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminosalicylate class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MESALAMINE DR 1.2 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE DR 1.2 GM TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.7809 per EA (NDC 63304017513), effective Sep 30, 2026.
How has the price of MESALAMINE DR 1.2 GM TABLET changed over time?
Over the history we have for it, the NADAC for MESALAMINE DR 1.2 GM TABLET has declined 77.4%. It has been tracked across 351 weekly CMS publications since Jan 15, 2020.
What are the highest and lowest recorded NADAC prices for MESALAMINE DR 1.2 GM TABLET?
Since Jan 15, 2020, the NADAC for MESALAMINE DR 1.2 GM TABLET has ranged from a low of $0.7809 (Sep 23, 2026) to a high of $3.5143 (Jan 13, 2021), with a median of $2.1176 per EA.
Are there cheaper alternatives to MESALAMINE DR 1.2 GM TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MESALAMINE DR 1.2 GM TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MESALAMINE DR 1.2 GM TABLET?
MESALAMINE DR 1.2 GM TABLET (NDC 63304017513) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.